Cargando…

The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency

Hereditary angioedema (HAE) is a rare condition, mostly due to genetic deficiency of complement C1 inhibitor (C1-INH). The rarity of HAE impedes extensive data collection and assessment of the impact of certain factors known to affect the course of this disabling and life-threatening disease. Establ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zanichelli, Andrea, Farkas, Henriette, Bouillet, Laurance, Bara, Noemi, Germenis, Anastasios E., Psarros, Fotis, Varga, Lilian, Andrási, Noemi, Boccon-Gibod, Isabelle, Castiglioni Roffia, Marco, Rutkowski, Michal, Cancian, Mauro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282542/ https://www.ncbi.nlm.nih.gov/pubmed/33791951 http://dx.doi.org/10.1007/s12016-021-08855-4

Ejemplares similares

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series
por: Maurer, Marcus, et al.
Publicado: (2022)

Overview of SERPING1 Variations Identified in Hungarian Patients With Hereditary Angioedema
por: Szabó, Edina, et al.
Publicado: (2022)

Diagnosing Pediatric Patients With Hereditary C1-Inhibitor Deficiency—Experience From the Hungarian Angioedema Center of Reference and Excellence
por: Andrási, Noémi, et al.
Publicado: (2022)

The characteristics of upper airway edema in hereditary and acquired angioedema with C1‐inhibitor deficiency
por: Balla, Zsuzsanna, et al.
Publicado: (2021)

Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant
por: Bouillet, Laurence, et al.
Publicado: (2017)

Hypersensitivity reactions amongst Hungarian Patients with Hereditary Angioedema due to C1-Inhibitor Deficiency
por: Horváth, Hanga Réka, et al.
Publicado: (2023)

Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)
por: Parsopoulou, Faidra, et al.
Publicado: (2022)

The analysis of the effect of the COVID-19 pandemic on patients with hereditary angioedema type I and type II
por: Szilágyi, Dávid, et al.
Publicado: (2023)

Application of a dried blood spot based proteomic and genetic assay for diagnosing hereditary angioedema
por: Iuraşcu, Marius‐Ionuţ, et al.
Publicado: (2023)

Profile of serious angioedema requiring an urgent advice from a national reference call center
por: Simon, Nicolas, et al.
Publicado: (2022)

Screening for Plasminogen Mutations in Hereditary Angioedema Patients
por: Farkas, Henriette, et al.
Publicado: (2021)

Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor
por: Loules, Gedeon, et al.
Publicado: (2020)

Rediscovery of a forgotten disease: Hereditary Angioedema
por: Gülbahar, Okan, et al.
Publicado: (2021)

Editorial: C1 inhibitor deficiency and angioedema
por: Farkas, Henriette, et al.
Publicado: (2022)

Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2011)

Anti-cholesterol antibody levels in hereditary angioedema
por: Varga, Lilian, et al.
Publicado: (2007)

Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2014)

455 Characterization of the Factors Triggering an Edematous Attack in Hereditary Angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2012)

Hereditary angioedema in women
por: Bouillet, Laurence
Publicado: (2010)

The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
por: Maurer, Marcus, et al.
Publicado: (2022)

Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants
por: Marceau, François, et al.
Publicado: (2020)

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey
por: Longhurst, H. J., et al.
Publicado: (2017)

The effect of long-term danazol treatment on haematological parameters in hereditary angioedema
por: Kőhalmi, Kinga Viktória, et al.
Publicado: (2016)

Consequences of Misdiagnosed and Mismanaged Hereditary Angioedema Laryngeal Attacks: An Overview of Cases from the Romanian Registry
por: Moldovan, Dumitru, et al.
Publicado: (2018)

Home treatment with conestat alfa in attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2015)

Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency
por: Farkas, Henriette, et al.
Publicado: (2012)

Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry()
por: Valerieva, Anna, et al.
Publicado: (2021)

Erratum to: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency
por: Farkas, Henriette, et al.
Publicado: (2012)

Management of upper airway edema caused by hereditary angioedema
por: Farkas, Henriette
Publicado: (2010)

Expert perspectives on hereditary angioedema: Key areas for advancements in care across the patient journey
por: Banerji, Aleena, et al.
Publicado: (2016)

The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency
por: Zotter, Zsuzsanna, et al.
Publicado: (2014)

Psychological processes in the experience of hereditary angioedema in adult patients: an observational study
por: Savarese, Livia, et al.
Publicado: (2021)

Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency
por: Kajdácsi, Erika, et al.
Publicado: (2021)

Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency
por: Veszeli, Nóra, et al.
Publicado: (2015)

Pediatric hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette
Publicado: (2010)

458 Differences of Complement Activation Profile between Type I and Type II of Hereditary Angioedema Due to C1-inhibitor Deficiency
por: Csuka, Dorottya, et al.
Publicado: (2012)

Dedicated call center (SOS-HAE) for hereditary angioedema attacks: study protocol for a randomised controlled trial
por: Javaud, Nicolas, et al.
Publicado: (2016)

Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment
por: Maurer, Marcus, et al.
Publicado: (2013)

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency
por: Farkas, H., et al.
Publicado: (2016)

Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Csuka, Dorottya, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ct4jdub9f7c735db7vcnhepj2a